Kenvue Inc. (NYSE:KVUE) Position Raised by APG Asset Management N.V.

APG Asset Management N.V. grew its position in shares of Kenvue Inc. (NYSE:KVUE) by 305.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 196,766 shares of the company’s stock after acquiring an additional 148,263 shares during the quarter. APG Asset Management N.V.’s holdings in Kenvue were worth $3,338,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of KVUE. Parallel Advisors LLC increased its position in Kenvue by 75.4% in the 4th quarter. Parallel Advisors LLC now owns 18,182 shares of the company’s stock valued at $391,000 after acquiring an additional 7,818 shares during the period. Stifel Financial Corp lifted its holdings in Kenvue by 60.4% in the fourth quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock worth $16,041,000 after purchasing an additional 280,591 shares during the period. Evoke Wealth LLC lifted its holdings in Kenvue by 3.9% in the fourth quarter. Evoke Wealth LLC now owns 30,256 shares of the company’s stock worth $651,000 after purchasing an additional 1,144 shares during the period. Scotia Capital Inc. grew its position in Kenvue by 86.8% in the 4th quarter. Scotia Capital Inc. now owns 50,083 shares of the company’s stock valued at $1,078,000 after buying an additional 23,268 shares in the last quarter. Finally, California State Teachers Retirement System increased its stake in Kenvue by 23.0% during the 4th quarter. California State Teachers Retirement System now owns 2,821,196 shares of the company’s stock valued at $60,740,000 after buying an additional 527,200 shares during the period. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. UBS Group boosted their price objective on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. Piper Sandler upped their price target on shares of Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. JPMorgan Chase & Co. lifted their price objective on shares of Kenvue from $22.00 to $24.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group began coverage on shares of Kenvue in a research report on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $22.10.

Kenvue Stock Up 0.6 %

KVUE stock opened at $23.26 on Monday. The business has a 50-day moving average of $21.41 and a 200-day moving average of $20.07. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $23.55. The stock has a market capitalization of $44.54 billion, a P/E ratio of 29.82, a P/E/G ratio of 2.92 and a beta of 1.40. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The business had revenue of $4 billion for the quarter, compared to analyst estimates of $3.93 billion. During the same quarter in the previous year, the firm posted $0.32 earnings per share. The firm’s revenue for the quarter was down .3% on a year-over-year basis. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.08 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were paid a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.53%. The ex-dividend date was Wednesday, August 14th. This is a boost from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s dividend payout ratio (DPR) is currently 105.13%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.